NAPIGEN Completes $7.85 Million Funding Round to Advance Its Mitochondrial and Chloroplast Gene Editing Technology

2 years ago

Funds will be used to develop hybrid seed technology in wheat and rice through gene editing of plant mitochondriaWILMINGTON, Del.,…

BioCardia to Participate in Upcoming Heart and Pulmonary Therapy Development Symposia

2 years ago

SUNNYVALE, Calif., July 12, 2022 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], Sunnyvale, Calif. – BioCardia®, Inc. [Nasdaq: BCDA], a developer of cellular and…

Akoya to Report Second Quarter 2022 Financial Results on August 8th, 2022

2 years ago

MARLBOROUGH, Mass., July 12, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced…

Agile Therapeutics Updates Second Quarter 2022 Guidance

2 years ago

Twirla® Demand Guidance (Total Cycles) Expected to be at Midpoint of Guided Range Operating Expenses (OPEX) Expected to be Below…

Reflect Scientific Inc Second Quarter Shareholder Letter

2 years ago

OREM, Utah, July 12, 2022 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF), a provider of diverse products and services…

electroCore Provides Select Second Quarter 2022 Financial Guidance

2 years ago

Record revenue will be at least $2.1 million; approximately 65% growth over second quarter 2021June 30, 2022, cash and cash…

scPharmaceuticals Inc. Announces Positive Results from the AT HOME-HF Phase 2 Pilot Study in Heart Failure

2 years ago

Study results favor FUROSCIX®versus “treatment as usual” in composite primary endpoint and all secondary endpoints FUROSCIX demonstrated an acceptable tolerability…

New Access Vascular Retrospective Data Review Demonstrates Midline Catheters Composed of Advanced Biomaterials May Improve Dwell Times

2 years ago

Data also finds using materials that mimic the body’s chemistry leads to meaningful reductions in complications such as phlebitis, occlusion,…

IN8bio Appoints Kenneth R. LaMontagne, Ph.D., to Lead Business Development

2 years ago

NEW YORK, July 12, 2022 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company focused on the discovery…

Alignment Healthcare to Introduce Award-Winning Medicare Advantage Plans with its Unique Care Model to Half a Million Medicare-Eligible Adults in Florida

2 years ago

ORANGE, Calif., July 12, 2022 (GLOBE NEWSWIRE) -- Alignment Healthcare (NASDAQ: ALHC), a tech-enabled Medicare Advantage company, will begin offering Alignment…